These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11785586)

  • 1. MMPI-2 scale F(p) and symptom feigning: scale refinement.
    Gass CS; Luis CA
    Assessment; 2001 Dec; 8(4):425-9. PubMed ID: 11785586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refinement of the MMPI-2 F(p) scale is not necessary: a response to Gass and Luis.
    Arbisi PA; Ben-Porath YS; McNulty J
    Assessment; 2003 Jun; 10(2):123-8. PubMed ID: 12801183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mild Brain Injury Atypical Symptoms (mBIAS) scale in a mixed clinical sample.
    Lippa SM; Axelrod BN; Lange RT
    J Clin Exp Neuropsychol; 2016 Sep; 38(7):721-9. PubMed ID: 27159359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of personality disorders with MMPI-2 malingering, defensiveness, and inconsistent response scales among forensic examinees.
    Wise EA
    Psychol Rep; 2002 Jun; 90(3 Pt 1):760-6. PubMed ID: 12090504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
    Gass CS; Odland AP
    J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMPI-2 L + K and L + K - F indexes of underreporting: normative and desirable responding.
    Brophy AL
    Psychol Rep; 2003 Feb; 92(1):223-7. PubMed ID: 12674286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMPI overreporting by Vietnam combat veterans.
    Hyer L; Fallon JH; Harrison WR; Boudewyns PA
    J Clin Psychol; 1987 Jan; 43(1):79-83. PubMed ID: 3558843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fake Bad Scale and MMPI-2 F-family in detection of implausible psychological trauma claims.
    Greiffenstein MF; Baker WJ; Axelrod B; Peck EA; Gervais R
    Clin Neuropsychol; 2004 Dec; 18(4):573-90. PubMed ID: 15841958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMPI-2 Symptom Validity (FBS) Scale: psychometric characteristics and limitations in a Veterans Affairs neuropsychological setting.
    Gass CS; Odland AP
    Appl Neuropsychol Adult; 2014; 21(1):1-8. PubMed ID: 24826489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of the MMPI-2-RF Henry-Heilbronner Index-r (HHI-r) scale.
    Henry GK; Heilbronner RL; Algina J; Kaya Y
    Clin Neuropsychol; 2013; 27(3):509-15. PubMed ID: 23157160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
    Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
    Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
    [No Abstract]   [Full Text] [Related]  

  • 14. Detecting symptom exaggeration and minimization using translated versions of the MMPI-2 and MMPI-2-RF: A systematic review and preliminary meta-analysis.
    Bopp LL; Aparcero M; Rosenfeld B
    Law Hum Behav; 2022 Feb; 46(1):81-97. PubMed ID: 35073117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normative data for the F(p) scale of the MMPI-2: implications for clinical and forensic assessment of malingering.
    Rothke SE; Friedman AF; Jaffe AM; Greene RL; Wetter MW; Cole P; Baker K
    Psychol Assess; 2000 Sep; 12(3):335-40. PubMed ID: 11021157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Mild Brain Injury Atypical Symptoms Scale to detect symptom exaggeration: an analogue simulation study.
    Lange RT; Edmed SL; Sullivan KA; French LM; Cooper DB
    J Clin Exp Neuropsychol; 2013; 35(2):192-209. PubMed ID: 23419145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the Neurobehavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury.
    Lange RT; Brickell TA; Lippa SM; French LM
    J Clin Exp Neuropsychol; 2015; 37(8):853-62. PubMed ID: 26245293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incremental validity and clinical utility of the MMPI-2 infrequency posttraumatic stress disorder scale.
    Marshall MB; Bagby RM
    Assessment; 2006 Dec; 13(4):417-29. PubMed ID: 17050912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Infrequency-Posttraumatic Stress Disorder scale (Fptsd) for the MMPI-2: development and initial validation with veterans presenting with combat-related PTSD.
    Elhai JD; Ruggiero KJ; Frueh BC; Beckham JC; Gold PB; Feldman ME
    J Pers Assess; 2002 Dec; 79(3):531-49. PubMed ID: 12511019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring symptom exaggeration in veterans with chronic posttraumatic stress disorder.
    Freeman T; Powell M; Kimbrell T
    Psychiatry Res; 2008 Apr; 158(3):374-80. PubMed ID: 18294699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.